Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Igniting Innovation, Catalyzing Changes: Bio Farma x MIT Hacking Medicine Hackathon Celebrates Success 2023-08-30 16:16
Cerecin to Present New Infantile Spasms Data at the 35th International Epilepsy Congress, Dublin 2023 2023-08-30 00:04
Viva Biotech (1873.HK) Announces 2023 Interim Results：Solid Growth in Main Business, Significant Rebound in Profitability 2023-08-29 22:38
Bayer Launches Stunting Prevention Program "CETING" for Community of Cisalak, Depok 2023-08-29 13:53
Ferinject® granted upgraded recommendations in 2023 ESC heart failure guidelines 2023-08-28 19:00
Jiangsu Recbio Technology Co., Ltd. announced 2023 interim results report and latest progress 2023-08-28 11:08
Antengene Announces Interim Financial Results for 2023 with New Clinical Data Highlighting the Growing Value of Its Pipeline 2023-08-25 19:37
Henlius 2023 H1 Results: Achieved record profits and RMB2.5 billion revenues, opening a new chapter of high-quality growth 2023-08-25 19:26
3SBio announces 2023 interim results, with revenue growing over 20% year on year and pipeline value constantly enhanced 2023-08-25 10:06
Everest Medicines Announces New Drug Application Acceptance by the Pharmaceutical Administration Bureau of Macao for Nefecon® for the Treatment of Primary IgA Nephropathy 2023-08-25 08:15
Antheia Achieves Major Commercial Milestone 2023-08-25 08:01
YS Biopharma Announces Purchase of Shares by Company Officers 2023-08-25 04:15
Everest Medicines Announces Interim Results for First Half of 2023 2023-08-24 08:15
Innovent Announces 2023 Interim Results and Business Updates 2023-08-23 19:38
Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company 2023-08-23 17:40
USANA Philippines Celebrates Legacy of Wellness Empowerment With Enterprise Asia Linchpin of Asia Awards 2023 2023-08-23 17:06
Lynk Pharmaceuticals Announces Positive Topline Data from Phase II Clinical Trial of LNK01001 in the Treatment of Ankylosing Spondylitis 2023-08-23 08:00
Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results 2023-08-22 22:00
Hummingbird Bioscience to Present Poster on HMBD-001 Combination Strategy for Squamous Non-Small Cell Lung Cancer at World Conference on Lung Cancer 2023 2023-08-21 17:58
Everest Medicines Announces Partner Calliditas Therapeutics Receives FDA Priority Review for Full Approval of Nefecon® for the Treatment of IgA Nephropathy 2023-08-21 08:20
1 24 25 26 27 28 230